Insider · CIK 0001866219
Charles W. Newton
Files at NVAX (NOVAVAX INC), CHRS (Coherus Oncology, Inc.), LYEL (Lyell Immunopharma, Inc.), TSVT (2seventy bio, Inc.). First filing Aug 13, 2025, latest Aug 22, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LYEL: Lyell Immunopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Lyell Immunopharma, Inc. | $15k 1,453 shares | -9% | +37% from low-66% from high | |
| 37Weak | Lyell Immunopharma, Inc. | $2,785 267 shares | -3% | +36% from low-66% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | LYEL Lyell Immunopharma, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 16,759 | Aug 22, 2025 |
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -1,453 | $10.54 | $15k | 15,306 | Aug 22, 2025 |
| Aug 11, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -131 | $10.53 | $1,379 | 8,895 | Aug 13, 2025 |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -136 | $10.34 | $1,406 | 8,759 | Aug 13, 2025 |
| Jun 12, 2025 | CHRS Coherus Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +112,000 | $0.00 | $0 | 112,000 | Jun 13, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Common Stock | -17,092 | - | - | 5,533 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | UTender of shares Common Stock | -5,533 | - | - | 0 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -33,400 | - | - | 0 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -12,050 | - | - | 0 | May 15, 2025 |
| Apr 25, 2025 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to buy)derivative | +42,840 | $0.00 | $0 | 42,840 | Apr 29, 2025 |
| Apr 25, 2025 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +28,560 | $0.00 | $0 | 28,560 | Apr 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.